Krka’s Consecutive Growth Fuels Investment Plans

Given the consecutive growth Krka has seen in its prescription pharmaceuticals portfolio along with an increase in overall sales, the company has announced investments of €134m in infrastructure and production facilities. This follows a €30m investment in the first half of 2020.